Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20091
20102
20112
20152
20162
20202
20212
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated4
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Incyte Corporation2
Bristol-Myers Squibb1
Celgene1
Eli Lilly and Company1
Gilead Sciences1
Hamilton Health Sciences Corporation1
Human Genome Sciences Inc.1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome19
Graft vs Host Disease3
Chronic Urticaria2
Leukemia2
Lymphoma, Follicular2
Pulmonary Disease, Chronic Obstructive2
Respiration Disorders2
Urticaria2
Anemia, Refractory, with Excess of Blasts1
Bronchiolitis Obliterans1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.